Global Psychotropic Drug Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: G6CA53822080EN
QYResearch

Abstracts

This report focuses on the global Psychotropic Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psychotropic Drug development in North America, Europe and Asia-Pacific.
The key players covered in this study

• Pfizer
• Ely Lilly
• Actavis
• Mylan
• Randox
• Fujifilm

Market segment by Type, the product can be split into

• Analgesics
• Anesthetics
• Hypnotics
• Others

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Psychotropic Drug status, future forecast, growth opportunity, key market and key players.
• To present the Psychotropic Drug development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Psychotropic Drug are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psychotropic Drug Revenue
1.4 Market Analysis by Type
  1.4.1 Global Psychotropic Drug Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Analgesics
  1.4.3 Anesthetics
  1.4.4 Hypnotics
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Psychotropic Drug Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Psychotropic Drug Industry Impact
  1.6.1 How the Covid-19 is Affecting the Psychotropic Drug Industry
    1.6.1.1 Psychotropic Drug Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Psychotropic Drug Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Psychotropic Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Psychotropic Drug Market Perspective (2015-2026)
2.2 Psychotropic Drug Growth Trends by Regions
  2.2.1 Psychotropic Drug Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Psychotropic Drug Historic Market Share by Regions (2015-2020)
  2.2.3 Psychotropic Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Psychotropic Drug Market Growth Strategy
  2.3.6 Primary Interviews with Key Psychotropic Drug Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Psychotropic Drug Players by Market Size
  3.1.1 Global Top Psychotropic Drug Players by Revenue (2015-2020)
  3.1.2 Global Psychotropic Drug Revenue Market Share by Players (2015-2020)
  3.1.3 Global Psychotropic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Psychotropic Drug Market Concentration Ratio
  3.2.1 Global Psychotropic Drug Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Psychotropic Drug Revenue in 2019
3.3 Psychotropic Drug Key Players Head office and Area Served
3.4 Key Players Psychotropic Drug Product Solution and Service
3.5 Date of Enter into Psychotropic Drug Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Psychotropic Drug Historic Market Size by Type (2015-2020)
4.2 Global Psychotropic Drug Forecasted Market Size by Type (2021-2026)

5 PSYCHOTROPIC DRUG BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Psychotropic Drug Market Size by Application (2015-2020)
5.2 Global Psychotropic Drug Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Psychotropic Drug Market Size (2015-2020)
6.2 Psychotropic Drug Key Players in North America (2019-2020)
6.3 North America Psychotropic Drug Market Size by Type (2015-2020)
6.4 North America Psychotropic Drug Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Psychotropic Drug Market Size (2015-2020)
7.2 Psychotropic Drug Key Players in Europe (2019-2020)
7.3 Europe Psychotropic Drug Market Size by Type (2015-2020)
7.4 Europe Psychotropic Drug Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Psychotropic Drug Market Size (2015-2020)
8.2 Psychotropic Drug Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Psychotropic Drug Market Size by Type (2015-2020)
8.4 Asia-Pacific Psychotropic Drug Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Pfizer
  9.1.1 Pfizer Company Details
  9.1.2 Pfizer Business Overview and Its Total Revenue
  9.1.3 Pfizer Psychotropic Drug Introduction
  9.1.4 Pfizer Revenue in Psychotropic Drug Business (2015-2020))
  9.1.5 Pfizer Recent Development
9.2 Ely Lilly
  9.2.1 Ely Lilly Company Details
  9.2.2 Ely Lilly Business Overview and Its Total Revenue
  9.2.3 Ely Lilly Psychotropic Drug Introduction
  9.2.4 Ely Lilly Revenue in Psychotropic Drug Business (2015-2020)
  9.2.5 Ely Lilly Recent Development
9.3 Actavis
  9.3.1 Actavis Company Details
  9.3.2 Actavis Business Overview and Its Total Revenue
  9.3.3 Actavis Psychotropic Drug Introduction
  9.3.4 Actavis Revenue in Psychotropic Drug Business (2015-2020)
  9.3.5 Actavis Recent Development
9.4 Mylan
  9.4.1 Mylan Company Details
  9.4.2 Mylan Business Overview and Its Total Revenue
  9.4.3 Mylan Psychotropic Drug Introduction
  9.4.4 Mylan Revenue in Psychotropic Drug Business (2015-2020)
  9.4.5 Mylan Recent Development
9.5 Randox
  9.5.1 Randox Company Details
  9.5.2 Randox Business Overview and Its Total Revenue
  9.5.3 Randox Psychotropic Drug Introduction
  9.5.4 Randox Revenue in Psychotropic Drug Business (2015-2020)
  9.5.5 Randox Recent Development
9.6 Fujifilm
  9.6.1 Fujifilm Company Details
  9.6.2 Fujifilm Business Overview and Its Total Revenue
  9.6.3 Fujifilm Psychotropic Drug Introduction
  9.6.4 Fujifilm Revenue in Psychotropic Drug Business (2015-2020)
  9.6.5 Fujifilm Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Psychotropic Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Psychotropic Drug Revenue
Table 3. Ranking of Global Top Psychotropic Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Psychotropic Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Analgesics
Table 6. Key Players of Anesthetics
Table 7. Key Players of Hypnotics
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Psychotropic Drug Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Psychotropic Drug Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Psychotropic Drug Players to Combat Covid-19 Impact
Table 14. Global Psychotropic Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Psychotropic Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Psychotropic Drug Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Psychotropic Drug Market Share by Regions (2015-2020)
Table 18. Global Psychotropic Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Psychotropic Drug Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Psychotropic Drug Market Growth Strategy
Table 24. Main Points Interviewed from Key Psychotropic Drug Players
Table 25. Global Psychotropic Drug Revenue by Players (2015-2020) (Million US$)
Table 26. Global Psychotropic Drug Market Share by Players (2015-2020)
Table 27. Global Top Psychotropic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotropic Drug as of 2019)
Table 28. Global Psychotropic Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Psychotropic Drug Product Solution and Service
Table 31. Date of Enter into Psychotropic Drug Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Psychotropic Drug Market Size by Type (2015-2020) (Million US$)
Table 34. Global Psychotropic Drug Market Size Share by Type (2015-2020)
Table 35. Global Psychotropic Drug Revenue Market Share by Type (2021-2026)
Table 36. Global Psychotropic Drug Market Size Share by Application (2015-2020)
Table 37. Global Psychotropic Drug Market Size by Application (2015-2020) (Million US$)
Table 38. Global Psychotropic Drug Market Size Share by Application (2021-2026)
Table 39. North America Key Players Psychotropic Drug Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Psychotropic Drug Market Share (2019-2020)
Table 41. North America Psychotropic Drug Market Size by Type (2015-2020) (Million US$)
Table 42. North America Psychotropic Drug Market Share by Type (2015-2020)
Table 43. North America Psychotropic Drug Market Size by Application (2015-2020) (Million US$)
Table 44. North America Psychotropic Drug Market Share by Application (2015-2020)
Table 45. Europe Key Players Psychotropic Drug Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Psychotropic Drug Market Share (2019-2020)
Table 47. Europe Psychotropic Drug Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Psychotropic Drug Market Share by Type (2015-2020)
Table 49. Europe Psychotropic Drug Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Psychotropic Drug Market Share by Application (2015-2020)
Table 51. Asia-Pacific Key Players Psychotropic Drug Revenue (2019-2020) (Million US$)
Table 52. Asia-Pacific Key Players Psychotropic Drug Market Share (2019-2020)
Table 53. Asia-Pacific Psychotropic Drug Market Size by Type (2015-2020) (Million US$)
Table 54. Asia-Pacific Psychotropic Drug Market Share by Type (2015-2020)
Table 55. Asia-Pacific Psychotropic Drug Market Size by Application (2015-2020) (Million US$)
Table 56. Asia-Pacific Psychotropic Drug Market Share by Application (2015-2020)
Table 57. Pfizer Company Details
Table 58. Pfizer Business Overview
Table 59. Pfizer Product
Table 60. Pfizer Revenue in Psychotropic Drug Business (2015-2020) (Million US$)
Table 61. Pfizer Recent Development
Table 62. Ely Lilly Company Details
Table 63. Ely Lilly Business Overview
Table 64. Ely Lilly Product
Table 65. Ely Lilly Revenue in Psychotropic Drug Business (2015-2020) (Million US$)
Table 66. Ely Lilly Recent Development
Table 67. Actavis Company Details
Table 68. Actavis Business Overview
Table 69. Actavis Product
Table 70. Actavis Revenue in Psychotropic Drug Business (2015-2020) (Million US$)
Table 71. Actavis Recent Development
Table 72. Mylan Company Details
Table 73. Mylan Business Overview
Table 74. Mylan Product
Table 75. Mylan Revenue in Psychotropic Drug Business (2015-2020) (Million US$)
Table 76. Mylan Recent Development
Table 77. Randox Company Details
Table 78. Randox Business Overview
Table 79. Randox Product
Table 80. Randox Revenue in Psychotropic Drug Business (2015-2020) (Million US$)
Table 81. Randox Recent Development
Table 82. Fujifilm Company Details
Table 83. Fujifilm Business Overview
Table 84. Fujifilm Product
Table 85. Fujifilm Revenue in Psychotropic Drug Business (2015-2020) (Million US$)
Table 86. Fujifilm Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Psychotropic Drug Market Share by Type: 2020 VS 2026
Figure 2. Analgesics Features
Figure 3. Anesthetics Features
Figure 4. Hypnotics Features
Figure 5. Others Features
Figure 6. Global Psychotropic Drug Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Psychotropic Drug Report Years Considered
Figure 11. Global Psychotropic Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Psychotropic Drug Market Share by Regions: 2020 VS 2026
Figure 13. Global Psychotropic Drug Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Psychotropic Drug Market Share by Players in 2019
Figure 16. Global Top Psychotropic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotropic Drug as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Psychotropic Drug Revenue in 2019
Figure 18. North America Psychotropic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Psychotropic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Asia-Pacific Psychotropic Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Pfizer Revenue Growth Rate in Psychotropic Drug Business (2015-2020)
Figure 23. Ely Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Ely Lilly Revenue Growth Rate in Psychotropic Drug Business (2015-2020)
Figure 25. Actavis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Actavis Revenue Growth Rate in Psychotropic Drug Business (2015-2020)
Figure 27. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Mylan Revenue Growth Rate in Psychotropic Drug Business (2015-2020)
Figure 29. Randox Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Randox Revenue Growth Rate in Psychotropic Drug Business (2015-2020)
Figure 31. Fujifilm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Fujifilm Revenue Growth Rate in Psychotropic Drug Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed